RxDoctor Payments Data

Anita Pillai, MD

Internal Medicine · Hinsdale, ILNPI 1972554038

Payments from drug & device makers

$603in general payments, 2019–2025

Across 32 payments — averaging $18.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$117
  • AstraZeneca$86
  • GSK$81
  • AbbVie$63
  • Amgen$58
  • Lilly USA, LLC$58
  • plus $139 from 5 others

What the payments were for

  • Food & beverage$603100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$603 in reported general payments places this provider in the 70th percentile of 5,182 internal medicine providers in Illinois.

See all internal medicine providers in Illinois

Medicare billing

Part B allowed, 2024
$282,505
Medicare patients
331
Services billed
7,505

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin113$151,010
OzempicSemaglutide57$102,877
JanuviaSitagliptin Phosphate50$80,575
EliquisApixaban56$72,911
TradjentaLinagliptin23$26,887
Tresiba Flextouch U-200Insulin Degludec16$25,545
MounjaroTirzepatide17$23,416
Combivent RespimatIpratropium/Albuterol Sulfate17$21,920
Breo ElliptaFluticasone/Vilanterol25$20,937
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog18$19,823
FarxigaDapagliflozin Propanediol12$15,585
Trelegy ElliptaFluticasone/Umeclidin/Vilanter13$15,533
Levothyroxine Sodium401$5,535
Rosuvastatin Calcium352$4,371
Atorvastatin Calcium417$4,156

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$117$102,87757 claims
PfizerEliquis$19$72,91156 claims
GSKBreo Ellipta, Trelegy Ellipta$81$36,47038 claims
Lilly USA, LLCMounjaro$58$23,41617 claims
AstraZenecaFarxiga$86$15,58512 claims
AbbVieSynthroid$63$2,08932 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 5,182 internal medicine providers in Illinois.

Other internal medicine in Hinsdale

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →